Literature DB >> 12530031

Expression of tissue factor is associated with clinical features and angiogenesis in prostate cancer.

Shoichiro Ohta1, Hideo Wada, Takahiro Nakazaki, Yoshinobu Maeda, Tsutomu Nobori, Hiroshi Shiku, Shin Nakamura, Osamu Nagakawa, Yuzo Furuya, Hideki Fuse.   

Abstract

BACKGROUND: Tissue factor (TF), the main initiator of blood coagulation, is involved in cancer metastasis and progression. We examined the role of TF on prostate cancer.
MATERIALS AND METHODS: Immunohistochemical analysis was performed using the anti-TF antibody. Intra-tumoral blood vessels were visualized by staining endothelial cells with CD34 antibody. We examined the expression of TF and the microvessel density (MVD) in 66 biopsy specimens of prostate cancer, in order to investigate the relationship between the expression of TF and the clinicopathology of prostate cancer.
RESULTS: TF antigen was positive in 41 (62%) of the specimens. There were significant differences in TF expression according to the pretreatment prostate specific antigen (PSA) level (p = 0.0193) and bone metastasis (p = 0.0029). MVD was significantly related to bone metastasis (p = 0.0175). TF-positive carcinomas more frequently presented high MVD expressions (p = 0.017) than TF-negative tumors.
CONCLUSION: These results suggest that increased angiogenesis associated with TF expression might cause the metastasis and progression of prostate cancer.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12530031

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  4 in total

1.  Expression of protease-activated receptors and tissue factor in human liver.

Authors:  Anne Rullier; Nathalie Senant; Walter Kisiel; Paulette Bioulac-Sage; Charles Balabaud; Brigitte Le Bail; Jean Rosenbaum
Journal:  Virchows Arch       Date:  2005-09-29       Impact factor: 4.064

2.  Population pharmacokinetic analysis for tisotumab vedotin in patients with locally advanced and/or metastatic solid tumors.

Authors:  Leonid Gibiansky; Chaitali Passey; Jenna Voellinger; Rudy Gunawan; William D Hanley; Manish Gupta; Helen Winter
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2022-08-06

3.  Differential expression of angiogenesis associated genes in prostate cancer bone, liver and lymph node metastases.

Authors:  Colm Morrissey; Lawrence D True; Martine P Roudier; Ilsa M Coleman; Sarah Hawley; Peter S Nelson; Roger Coleman; Ya-Chun Wang; Eva Corey; Paul H Lange; Celestia S Higano; Robert L Vessella
Journal:  Clin Exp Metastasis       Date:  2007-10-31       Impact factor: 5.150

4.  Symptomatic and incidental venous thromboembolic disease are both associated with mortality in patients with prostate cancer.

Authors:  Shruti Chaturvedi; Surbhi Sidana; Paul Elson; Alok A Khorana; Keith R McCrae
Journal:  PLoS One       Date:  2014-08-15       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.